Chlamydia
Overview
Nucleic acid amplification tests (NAATs) are the investigation of choice - highest sensitivity and specificity. Specimen type differs by sex and is the highest-yield exam distinction.
First-line investigation by sex
| Feature | Women | Men |
|---|---|---|
| First-line test | NAAT on vulvovaginal swab (self-taken from vaginal introitus) | NAAT on first-catch urine (first 10-20 mL) |
| Why not the alternative? | Endocervical swab is less sensitive and requires a clinician | Mid-stream urine is less sensitive than first-catch |
•Rectal or pharyngeal NAAT swab - if receptive anal or oral intercourse reported
•Full STI screen - all confirmed cases offered testing for gonorrhoea, HIV, syphilis, and hepatitis B
Presentation
•Majority of cases are asymptomatic (up to 70% of women, 50% of men)
•Women: mucopurulent vaginal discharge, intermenstrual or post-coital bleeding, dysuria, lower abdominal pain (suggests PID), cervicitis on speculum
•Men: urethral discharge (clear/white), dysuria, unilateral testicular pain and swelling (epididymo-orchitis)
Management
•First-line (non-pregnant): doxycycline 100 mg twice daily for 7 days
•Second-line (non-pregnant): azithromycin 1 g on day 1, then 500 mg once daily for 2 further days
•Second-line (non-pregnant): ofloxacin 200 mg twice daily for 7 days - contraindicated in pregnancy
•Pregnancy - first-line: azithromycin 1 g on day 1, then 500 mg once daily for 2 days
•Pregnancy - second-line: erythromycin 500 mg four times daily for 7 days (high GI side-effect burden)
•Pregnancy - second-line: amoxicillin 500 mg three times daily for 7 days (penicillins may induce chlamydial latency - discuss with GUM)
•Abstain from sexual intercourse for 7 days after completing treatment and until all partners have also completed treatment
•Partner notification - all partners from the preceding 6 months; approximately two-thirds will test positive
Follow-up
•Routine test of cure NOT required for most patients
•Pregnant women - test of cure 3-4 weeks after treatment
•Under-25s in England - repeat test 3 months after a positive result (high re-infection rates)
•Persistent symptoms or non-adherence - repeat NAAT at least 3 weeks after completing treatment